Literature DB >> 18513370

Tyrosine hydroxylase activity is regulated by two distinct dopamine-binding sites.

Sarah L Gordon1, Noelene S Quinsey, Peter R Dunkley, Phillip W Dickson.   

Abstract

Tyrosine hydroxylase (TH), the rate-limiting enzyme in the biosynthesis of the catecholamines dopamine, noradrenaline and adrenaline, is regulated acutely by feedback inhibition by the catecholamines and relief of this inhibition by phosphorylation of serine 40 (Ser40). Phosphorylation of serine 40 abolishes the binding of dopamine to a high affinity (K(D) < 4 nM) site on TH, thereby increasing the activity of the enzyme. We have found that TH also contains a second low affinity (K(D) = 90 nM) dopamine-binding site, which is present in both the non-phosphorylated and the Ser40-phosphorylated forms of the enzyme. Binding of dopamine to the high-affinity site decreases V(max) and increases the K(m) for the cofactor tetrahydrobiopterin, while binding of dopamine to the low-affinity site regulates TH activity by increasing the K(m) for tetrahydrobiopterin. Kinetic analysis indicates that both sites are present in each of the four human TH isoforms. Dissociation of dopamine from the low-affinity site increases TH activity 12-fold for the non-phosphorylated enzyme and 9-fold for the Ser40-phosphorylated enzyme. The low-affinity dopamine-binding site has the potential to be the primary mechanism responsible for the regulation of catecholamine synthesis under most conditions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18513370     DOI: 10.1111/j.1471-4159.2008.05509.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  14 in total

Review 1.  Tyrosine hydroxylase and regulation of dopamine synthesis.

Authors:  S Colette Daubner; Tiffany Le; Shanzhi Wang
Journal:  Arch Biochem Biophys       Date:  2010-12-19       Impact factor: 4.013

Review 2.  Complex molecular regulation of tyrosine hydroxylase.

Authors:  Izel Tekin; Robert Roskoski; Nurgul Carkaci-Salli; Kent E Vrana
Journal:  J Neural Transm (Vienna)       Date:  2014-05-28       Impact factor: 3.575

3.  Patterns of phosphorylated tyrosine hydroxylase vary with song production in female starlings.

Authors:  Jesse M S Ellis; Lauren V Riters
Journal:  Brain Res       Date:  2012-12-25       Impact factor: 3.252

4.  Compensatory regulation of dopamine after ablation of the tyrosine hydroxylase gene in the nigrostriatal projection.

Authors:  Hirofumi Tokuoka; Shin-ichi Muramatsu; Chiho Sumi-Ichinose; Hiroaki Sakane; Masayo Kojima; Yoshinori Aso; Takahide Nomura; Daniel Metzger; Hiroshi Ichinose
Journal:  J Biol Chem       Date:  2011-10-25       Impact factor: 5.157

5.  Relative efficiencies of plasma catechol levels and ratios for neonatal diagnosis of menkes disease.

Authors:  David S Goldstein; Courtney S Holmes; Stephen G Kaler
Journal:  Neurochem Res       Date:  2009-02-21       Impact factor: 3.996

6.  The low affinity dopamine binding site on tyrosine hydroxylase: the role of the N-terminus and in situ regulation of enzyme activity.

Authors:  Sarah L Gordon; Julianne K Webb; Jacqueline Shehadeh; Peter R Dunkley; Phillip W Dickson
Journal:  Neurochem Res       Date:  2009-05-16       Impact factor: 3.996

7.  Comparison of Monoamine Oxidase Inhibitors in Decreasing Production of the Autotoxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde in PC12 Cells.

Authors:  David S Goldstein; Yunden Jinsmaa; Patti Sullivan; Courtney Holmes; Irwin J Kopin; Yehonatan Sharabi
Journal:  J Pharmacol Exp Ther       Date:  2015-11-16       Impact factor: 4.030

8.  Effects of VMAT2 inhibitors lobeline and GZ-793A on methamphetamine-induced changes in dopamine release, metabolism and synthesis in vivo.

Authors:  Andrew C Meyer; Nichole M Neugebauer; Guangrong Zheng; Peter A Crooks; Linda P Dwoskin; Michael T Bardo
Journal:  J Neurochem       Date:  2013-08-20       Impact factor: 5.372

9.  L-Tyrosine availability affects basal and stimulated catecholamine indices in prefrontal cortex and striatum of the rat.

Authors:  Zachary D Brodnik; Manda Double; Rodrigo A España; George E Jaskiw
Journal:  Neuropharmacology       Date:  2017-05-29       Impact factor: 5.250

Review 10.  Glial Cell Line-Derived Neurotrophic Factor Gene Delivery in Parkinson's Disease: A Delicate Balance between Neuroprotection, Trophic Effects, and Unwanted Compensatory Mechanisms.

Authors:  Liliane Tenenbaum; Marie Humbert-Claude
Journal:  Front Neuroanat       Date:  2017-04-10       Impact factor: 3.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.